Showing results (61-70 of 183) with videos related to
Sort By:
Pageof 19
Journal of Lipid Research|May 1, 1982
Metabolism of plasma mevalonate in rats and humansR R Kopito, S B Weinstock, L E Freed, et al.The Cochrane Database of Systematic Reviews|January 10, 2003
Cyclophosphamide for multiple sclerosisL La Mantia, C Milanese, N Mascoli, et al.Digestive Diseases and Sciences|April 25, 2020
Mast Cell Activation Syndrome: A Primer for the GastroenterologistLeonard B Weinstock, Laura A Pace, Ali Rezaie, et al.Human Immunology|April 17, 1998
HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosisM Yu, R P Kinkel, B Weinstock-Guttman, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2006
Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosisS D Brass, R H B Benedict, B Weinstock-Guttman, et al.The British Journal of Dermatology|August 9, 2016
Rosacea and gastrointestinal disorders: a population-based cohort studyA Egeberg, L B Weinstock, E P Thyssen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysisS A Morrow, B Weinstock-Guttman, F E Munschauer, et al.Surgical Endoscopy|May 29, 1999
Laparoscopic removal of an Angelchik prosthesisR A Underwood, L B Weinstock, N J Soper, et al.Journal of the Neurological Sciences|July 5, 2005
MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosisC W Tjoa, R H B Benedict, B Weinstock-Guttman, et al.Journal of the International Neuropsychological Society : JINS|October 11, 2005
Interpreting patient/informant discrepancies of reported cognitive symptoms in MSD A Carone, R H B Benedict, F E Munschauer, et al.Pageof 19